EP3237001
Lyfjaafurðir og stöðugar fljótandi samsetningar af IL-17 mótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.12.2015EP published:
7.2.2024EP application number:
15823805.5
EP translation filed:
15.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
20.12.2035Expiry date:
20.12.2026Next due date:
31.12.2026
Title in English:
PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIESLanguage of the patent:
English
Timeline
Today
21.12.2015EP application
7.2.2024EP Publication
15.4.2024Translation submitted
15.5.2024Registration published
20.12.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
JOERG, SusanneAddress:
4002 Basel, CH
Name:
SERNO-SCHERSCH, KathrinAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462095210 PDate:
22.12.2014Country:
US
Classification
Categories:
A61K 39/395, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 28.11.2024
Expires: 20.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 19.12.2025
Expires: 20.12.2026
Payer: Árnason Faktor ehf.